Literature DB >> 16140188

A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair.

Negin Amanat1, Richard Brown, Lynne E Bilston, David G Little.   

Abstract

Complications in fracture repair that lead to a delay in union remain clinically problematic. We believe that unwanted pre-mature catabolism of the healing callus, for example, in stress shielded situations, diminishes the rate at which strength is restored in bone repair and possibly leads to delayed union. We hypothesized that a single systemic dose of a nitrogen-containing bisphosphonate (N-BP) would increase bone mineral content (BMC), volume, and mechanical strength of union in fracture repair. We also set out to investigate local delivery to assess whether systemic exposure could be eliminated, due to concerns of bisphosphonate dosing of non-target organs. After an open osteotomy fixed with a K wire, 40 12-week old Wistar male rats were divided into four groups of 10: saline control, bolus systemic subcutaneous injection of pamidronate (3 mg/kg), local low dose of pamidronate (0.1 mg), and a local high dose of pamidronate (1.0 mg). Rats were sacrificed 6 weeks post-operatively. Operated and non-operated femora underwent radiographic evaluation, quantitative computer tomography, and biomechanical testing in torsion. The growth plates and metaphyses of the tibia of the non-operated side were assessed for evidence of systemic exposure in the local groups. Significant increases in callus BMC and volume of the bolus systemic dose group were found compared to the saline control (p< or =0.05). Further, the strength of the systemic dose callus was increased by 60% from 0.35 Nm (+/-0.11) for the saline control callus to 0.56 Nm (+/-0.25) for the systemic group (p=0.05). Local treatment did not result in increased strength. The contralateral tibial growth plates of the local groups showed evidence of systemic exposure by the presence of retained primary spongiosa. This study confirms that a single perioperative systemic dose of pamidronate leads to significant increases in the BMC, volume, and strength of healing fractures in rats, making single dose N-BP therapy an appealing candidate for further examination in fracture repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140188     DOI: 10.1016/j.orthres.2005.03.004

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  31 in total

Review 1.  Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Y-T Li; H-F Cai; Z-L Zhang
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

2.  Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.

Authors:  Lee A Jennings; Andrew D Auerbach; Judith Maselli; Penelope S Pekow; Peter K Lindenauer; Sei J Lee
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

3.  Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.

Authors:  H P Bögl; P Aspenberg; J Schilcher
Journal:  Osteoporos Int       Date:  2017-05-04       Impact factor: 4.507

4.  Effect of zoledronic acid in an L6-L7 rabbit spine fusion model.

Authors:  Rick Bransford; Elisabeth Goergens; Julie Briody; Negin Amanat; Andrew Cree; David Little
Journal:  Eur Spine J       Date:  2006-09-12       Impact factor: 3.134

Review 5.  Orthobiologics in the augmentation of osteoporotic fractures.

Authors:  J Tracy Watson; Daemeon A Nicolaou
Journal:  Curr Osteoporos Rep       Date:  2015-02       Impact factor: 5.096

6.  Can an anti-fracture agent heal fractures?

Authors:  Thomas A Einhorn
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

7.  Pharmacological agents and bone healing.

Authors:  Umberto Tarantino; Irene Cerocchi; Monica Celi; Alessandro Scialdoni; Luca Saturnino; Elena Gasbarra
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

Review 8.  Use of bisphosphonates for the treatment of stress fractures in athletes.

Authors:  Yosuke Shima; Lars Engebretsen; Junji Iwasa; Katsuhiko Kitaoka; Katsuro Tomita
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-12-02       Impact factor: 4.342

9.  Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta.

Authors:  J A Meganck; D L Begun; J D McElderry; A Swick; K M Kozloff; S A Goldstein; M D Morris; J C Marini; M S Caird
Journal:  Bone       Date:  2013-06-14       Impact factor: 4.398

10.  Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function.

Authors:  Elise F Morgan; Zachary D Mason; Karen B Chien; Anthony J Pfeiffer; George L Barnes; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  Bone       Date:  2008-10-25       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.